Please set your featured image
Prosensa Wins Scrip ‘Biotech Company of the Year’ 2014 Award
Prosensa Holding N.V., the biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with a high unmet medical need, is delighted to have won the Scrip ‘Biotech Company of the Year’ Award for 2014, announced last week in London, UK. Prosensa, based in the Netherlands, opened its UK office at Oxford University Begbroke Science Park in 2010.
The prestigious Scrip Awards provide an opportunity to acknowledge and applaud the highest achievers across the biotechnology and pharmaceutical industry, recognizing both corporate and individual accomplishments. The award for ‘Biotech Company of the Year’ is given to the company which has demonstrated the greatest achievements for the year.
Hans Schikan, CEO of Prosensa, said, “Winning Scrip’s ‘Biotech Company of the Year’ Award is a great honour and a testament to the dedication and hard work of the Prosensa team. Our drive to succeed is fuelled by patients and their families, who continue to inspire us to make innovative therapies available as quickly and efficiently as possible.”
The other five finalists were: Ablynx; Horizon Discovery; Isis Pharmaceuticals; Mesoblast; and Silence Therapeutics.
Read more about Prosensa here